← Back to Search

Compression Device

Dayspring Active Wearable Compression System for Lymphedema (TIGRIS Trial)

N/A
Waitlist Available
Research Sponsored by Koya Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at day 28
Awards & highlights

TIGRIS Trial Summary

This study is evaluating whether a compression garment may help improve lymphatic function after surgery.

Eligible Conditions
  • Lymphedema

TIGRIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at day 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at day 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ICG Fluorescence Lymphatic Imaging

TIGRIS Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with Breast-cancer related lymphedema (BCRL) after lymphatic surgeryExperimental Treatment1 Intervention
Patients with Breast-cancer related lymphedema (BCRL) after lymphatic surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dayspring Active Wearable Compression System
2021
N/A
~60

Find a Location

Who is running the clinical trial?

Koya Medical, Inc.Lead Sponsor
5 Previous Clinical Trials
363 Total Patients Enrolled
5 Trials studying Lymphedema
363 Patients Enrolled for Lymphedema

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
2021. "A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04888975.
All > Lymphedema
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top